SEC Form D · Amendment · filed October 25, 2017
Realm Therapeutics plc
Location
LONDON, United Kingdom
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Marella Thorell · London, United KingdomExec · DirectorIvan W. Gergel · London, United KingdomDirectorMatthew W. Hammond · London, United KingdomDirectorJoseph W. Birkett · London, United KingdomDirectorCharles Spicer · London, United KingdomDirectorDaniel W. Hegglin · London, United KingdomDirectorBalkrishan W. Gill · London, United KingdomDirectorAlex Martin · London, United KingdomExec · DirectorEllen M. Levy · Salt Lake City, UTDirectorRyan Powers · HALLANDALE BEACH, FLDirectorSteven A. Collins · Salt Lake City, UTDirectorAlexandra Nussenbaum · HALLANDALE BEACH, FLDirectorLloyd G. Waterhouse · Salt Lake City, UTExec · DirectorWilliam M. Conroy · Salt Lake City, UTDirectorDaniel Goldsmith · Salt Lake City, UTDirectorAlex Martin · London, United KingdomExec · DirectorBen H. Harris · Lincoln, NEExec · DirectorTerry H. Dunn · Lincoln, NEDirectorDavid M. Hadani · Lincoln, NEDirectorKen H. Hager · Lincoln, NEDirectorJulie K. Hughes · Grand Cayman, Cayman IslandsDirectorBrandon C. Bellamy · Accokeek, MDExec · DirectorCynthia Padnos · Oakland, CADirectorMatthew Mcdonagh · NEW YORK, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗